These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 15078426

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic-type tinea pedis.
    Kikuchi I, Tanuma H, Morimoto K, Kawana S.
    Mycoses; 2008 Nov; 51(6):523-31. PubMed ID: 18422915
    [Abstract] [Full Text] [Related]

  • 3. Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis.
    Kikuchi I, Tanuma H, Morimoto K, Kawana S.
    Mycoses; 2008 Jan; 51(1):7-13. PubMed ID: 18076589
    [Abstract] [Full Text] [Related]

  • 4. Treatment of tinea pedis with a single pulse of itraconazole.
    Bonifaz A, Saúl A.
    Eur J Dermatol; 2002 Jan; 12(2):157-9. PubMed ID: 11872413
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of onychomycosis and tinea pedis with intermittent itraconazole therapy.
    Del Rosso JQ.
    J Am Osteopath Assoc; 1996 Oct; 96(10):607-9. PubMed ID: 8936929
    [Abstract] [Full Text] [Related]

  • 7. Usefulness of 1% terbinafine HCl (Lamisil) cream for hyperkeratotic-type tinea pedis and its transfer into the horny layer.
    Tanuma H, Doi M, Ohta Y, Nishiyama S, Katsuoka K, Kaneko S, Mukai H, Abe M.
    Mycoses; 2000 Oct; 43(11-12):417-32. PubMed ID: 11204359
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Evaluation the antimycotic activity of itraconazole in human stratum corneum with vitro fungi cultivation].
    Xu W, Zhao JY, Wang L.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 02; 85(8):530-3. PubMed ID: 15949332
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A case of bullous tinea pedis with dermatophytid reaction caused by Trichophyton violaceum.
    Romano C, Rubegni P, Ghilardi A, Fimiani M.
    Mycoses; 2006 May 02; 49(3):249-50. PubMed ID: 16681820
    [Abstract] [Full Text] [Related]

  • 13. A double blind study of itraconazole vs griseofulvin in patients with tinea pedis and tinea manus.
    Wishart JM.
    N Z Med J; 1994 Apr 13; 107(975):126-8. PubMed ID: 8145958
    [Abstract] [Full Text] [Related]

  • 14. Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis--comparison between three groups (1%, 0.5%, 0.1%) by a multi-center randomised double-blind study.
    Watanabe S, Takahashi H, Nishikawa T, Takiuchi I, Higashi N, Nishimoto K, Kagawa S, Yamaguchi H, Ogawa H.
    Mycoses; 2007 Jan 13; 50(1):35-40. PubMed ID: 17302746
    [Abstract] [Full Text] [Related]

  • 15. D-optimal experimental approach for designing topical microemulsion of itraconazole: Characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats.
    Kumar N, Shishu.
    Eur J Pharm Sci; 2015 Jan 25; 67():97-112. PubMed ID: 25445834
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of a single 400 mg dose versus a 7-day 200 mg daily dose of itraconazole in the treatment of tinea versicolor.
    Köse O, Bülent Taştan H, Riza Gür A, Kurumlu Z.
    J Dermatolog Treat; 2002 Jun 25; 13(2):77-9. PubMed ID: 12060506
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy.
    Boogaerts MA, Maertens J, Van Der Geest R, Bosly A, Michaux JM, Van Hoof A, Cleeren M, Wostenborghs R, De Beule K.
    Antimicrob Agents Chemother; 2001 Mar 25; 45(3):981-5. PubMed ID: 11181397
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.